{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Reclassification to Current Clinical Guidelines\n",
    "\n",
    "```{contents}\n",
    "```"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Current thinking:\n",
    "\n",
    "14 WHO subtypes of AML\n",
    "+1 otherwise-normal control\n",
    "+1 mds-like and secondary neoplasms\n",
    "\n",
    "Need to figure out how to deal with really rare subtypes (e.g. AML FUS-ERG, KAT6A)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Guidelines"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### WHO 2022"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "source": [
    "| Subtype                         | Frequency in paediatric AML | Morphology                                                                                  | Immunophenotype                                                                                                                                              | Common co-occurring genetic aberrations                                                                | Prognosis                           |\n",
    "|---------------------------------|-----------------------------|--------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|-------------------------------------|\n",
    "| AML with RUNX1::RUNXT1 fusion   | 13–19% of cases             | Neutrophilic maturation, Auer rods; often increased basophils and/or mast cells            | Positive: CD34, HLA-DR, KIT (CD117), CD99, myeloperoxidase Usually positive but can be heterogeneous: CD13, CD33 and CD38, CD19, PAX5, cytoplasmic CD79a, CD56 Negative: CD7 | Mutations in KIT, FLT3, CSF3R, EZH2, ASXL1, ASXL2, CBL, WT1, cohesion genes (SMC1A, SMC3, RAD21), NRAS, KRAS | Good                                |\n",
    "| AML with CBFB::MYH11 fusion     | 7–12% of cases              | Myelomonocytic; often increased eosinophils at all maturation stages                        | Often multiple blast populations with signs of differentiation towards both granulocytic and monocytic lineages; may express CD2 and/or NG2 in a small subpopulation of cells                                 | Mutations in KIT, KRAS, NRAS, CBL, FLT3, WT1                                                            | Good                                |\n",
    "| APL with PML::RARA fusion       | 5–10% of cases but wide geographical variation (2–50%) | Exclusively FAB M3; may be hypogranular                                                    | Positive: CD33, often KIT (CD117), sometimes CD2 Negative: CD34 (except hypogranular variant), HLA-DR Often high autofluorescence                         | Mutations in FLT3                                                                               | Good (but treated differently)      |\n",
    "| AML with KMT2A rearrangement    | 20% of cases               | All FAB types except M3 and M6, most commonly M5                                           | Positive: CD33, CD65, CD4, HLA-DR (in monocytic cases), CD15, NG2; platelet antigens (in megakaryocytic cases) Negative/low: CD13, CD34, CD14               | Mutations in the tyrosine kinase, PI3K, and RAS pathways; FLT3-TKD, NRAS, KRAS                      | Depends on fusion partner           |\n",
    "| AML with DEK::NUP214 fusion     | 1–2% of cases              | All FAB types except M3 and M7, most commonly M2 and M4; Auer rods; basophilia in blood or bone marrow; erythroid and granulocytic dysplasia are common | Positive: myeloperoxidase, CD13, CD33, CD38, CD123, HLA-DR; often CD34, KIT (CD117), CD15; sometimes CD64, TdT                                               | FLT3 ITD in two thirds of cases; complex karyotype                                                   | Poor                                |\n",
    "| AML with MECOM rearrangement    | < 1% of cases              | Commonly FAB M1, M4, and M7; multilineage dysplasia is common, especially in megakaryopoiesis | Positive: CD34, CD33, CD13, KIT (CD117), HLA-DR, CD7 Negative: lymphoid markers other than CD7                                                               | n/a                                                                                         | Poor                                |\n",
    "| AML with ETV6 fusion            | 1% of all cases            | All FAB types, most commonly M0 and M1                                                     | For MNX1::ETV6: Positive: CD34, HLA-DR, often KIT (CD117), T-cell markers CD7 and CD4                                                                       | Almost always +19, sometimes +8                                                           | Poor, but may be protocol dependent |\n",
    "| AML with KAT6A::CREBBP fusion   | 0.5% of cases               | FAB M5                                                                                     | Positive: HLA-DR, CD15, myeloperoxidase, CD13, CD33, sometimes CD56, CD14 Negative: CD34, KIT (CD117)                                                       | n/a                                                                                        | OS similar to paediatric AML in general |\n",
    "| AML with RBM15::MRTFA fusion    | 0.8% of all cases           | Exclusively FAB M7                                                                         | Positive: > 1 platelet antigen, some CD34 and/or HLA-DR Negative: CD45                                                                                      | del(1p), +4, +7, +8, +9, +10, +14, +15, +17, +18, +20, +21(21p), complex hyperdiploid karyotype      | Lower CR rate but similar EFS/OS vs other AMKLs |\n",
    "| AML with CBFA2T3::GLIS2 fusion  | 3% of all cases             | All FAB types, most commonly M7                                                             | > 50% show the RAM phenotype; overexpression of CD56 and underexpression of HLA-DR and CD38                                                                  | Mutations in FLT3, GATA1, JAK/STAT pathway                                                               | Poor                                |\n",
    "| AML with NUP98 rearrangement    | 5–9% of cases               | NUP98::NSD1: often FAB M4 and M5 NUP98::KDM5A: mostly FAB M7 but also M5 and M6            | n/a                                                                                                                                                           | For NUP98::NSD1: FLT3 ITD in > 80%, mutation in WT1 in 50%                                              | Poor                                |\n",
    "| AML with FUS::ERG fusion        | 0.3–0.5% of cases           | All FAB types except M6; Auer rods                                                         | n/a                                                                                                                                                           | +8, +10, complex karyotype                                                                   | Poor                                |\n",
    "| AML with NPM1 mutation          | 6–8% of cases               | FAB M1, M2, M4, and M5                                                                     | Positive: CD33, sometimes KIT (CD117), often CD36, CD64 Negative: CD34, sometimes HLA-DR Often weak CD13                                                     | FLT3 ITD, mutations in NRAS, WT1                                                             | Good, also when FLT3 ITD is present |\n",
    "| AML with CEBPA mutation         | 5–6% of cases               | Most commonly FAB M1 and M2                                                                | Positive: CD34, HLA-DR, often CD7 Negative: other lymphoid antigens                                                                                          | Mutations in CEBPA-TAD, CSF3R, GATA2, RAS genes, FLT3                                                 | Good, except for CSF3R-mutated cases |\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "`````{admonition} Source\n",
    ":class: tip\n",
    "Hasle H, Meshinchi S, Fogelstrand L, Alaggio R, et al. Acute myeloid leukaemias (AMLs) with defining genetic abnormalities. In: WHO Classification of Tumours Editorial Board. Paediatric tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2024 Jan 1]. (WHO classification of tumours series, 5th ed.; vol. 7). Available from: https://tumourclassification.iarc.who.int/chapters/44.\n",
    "`````"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary ICD-O Coding\n",
    "\n",
    "9866/3 Acute promyelocytic leukaemia with PML::RARA fusion\n",
    "\n",
    "9896/3 AML with RUNX1::RUNX1T1 fusion\n",
    "\n",
    "9871/3 AML with CBFB::MYH11 fusion\n",
    "\n",
    "9897/3 AML with KMT2A rearrangement\n",
    "\n",
    "9877/3 AML with NPM1 mutation\n",
    "\n",
    "9869/3 AML with MECOM rearrangement\n",
    "\n",
    "9865/3 AML with DEK::NUP214 fusion\n",
    "\n",
    "9911/3 AML with RBM15::MRTFA fusion\n",
    "\n",
    "9912/3 AML with BCR::ABL1 fusion\n",
    "\n",
    "9861/3 AML with NUP98 rearrangement\n",
    "\n",
    "9878/3 AML with CEBPA mutation\n",
    "\n",
    "9861/3 AML with MNX1::ETV6 fusion\n",
    "\n",
    "9861/3 AML with KAT6A::CREBBP fusion\n",
    "\n",
    "9861/3 AML with CBFA2T3::GLIS2 fusion"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Load and process clinical data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The clinical data has been indexed and cleaned.\n",
      "Exclusion of samples may be applied depending on the analysis.\n"
     ]
    }
   ],
   "source": [
    "# Import functions to clean up clinical data\n",
    "import sys\n",
    "sys.path.insert(0, '..')\n",
    "from source.clinical_data_cleanup_functions import *\n",
    "\n",
    "# Call functions to merge, index and clean clinical data files\n",
    "labels_0531         = clean_cog       (merge_index_0531())\n",
    "labels_1031         = clean_cog       (merge_index_1031())\n",
    "labels_aml05        = clean_aml05     (merge_index_aml05())\n",
    "labels_beataml      = clean_beataml   (merge_index_beataml())\n",
    "labels_amltcga      = clean_amltcga   (merge_index_amltcga())\n",
    "labels_nordic_all   = clean_nordic_all(merge_index_nordic_all())\n",
    "labels_mds_taml     = clean_mds_taml  (merge_index_mds_taml())\n",
    "labels_all_graal    = clean_all_graal (merge_index_all_graal())\n",
    "labels_target_all   = clean_target_all(merge_index_target_all())\n",
    "\n",
    "# Combine all clinical data labels into one dataframe\n",
    "labels_combined = pd.concat([labels_aml05, labels_beataml,\n",
    "                        labels_0531, labels_amltcga, labels_1031,\n",
    "                        labels_nordic_all, labels_mds_taml,\n",
    "                        labels_all_graal,labels_target_all],\n",
    "                        axis=0, join='outer')\n",
    "\n",
    "# Redefine output path (for troubleshooting purposes in case only this cell is run)\n",
    "output_path = '../../Data/Intermediate_Files/'\n",
    "\n",
    "# Read df\n",
    "df = pd.read_pickle(output_path + '3330samples-333351cpgs-withbatchcorrection-bvalues.pkl')\n",
    "\n",
    "# Remove samples that are not in the methyl dataset\n",
    "df_labels = labels_combined.loc[labels_combined.index.isin(df.index)].sort_index()\n",
    "\n",
    "# Add age categorization and main disease classification to the clinical data\n",
    "# df_labels = process_df_labels(df_labels)\n",
    "\n",
    "# Save the clinical data labels\n",
    "# df_labels.to_csv(output_path + 'discovery_clinical_data.csv')\n",
    "\n",
    "print('The clinical data has been indexed and cleaned.\\n\\\n",
    "Exclusion of samples may be applied depending on the analysis.')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [],
   "source": [
    "# save all label dataframes into excel files using `pandas` 'to_excel' function\n",
    "# labels_aml05.to_excel(output_path + 'aml05_clinical_data.xlsx')\n",
    "# labels_beataml.to_excel(output_path + 'beataml_clinical_data.xlsx')\n",
    "labels_0531.to_excel(output_path + '0531_clinical_data.xlsx')\n",
    "# labels_amltcga.to_excel(output_path + 'amltcga_clinical_data.xlsx')\n",
    "labels_1031.to_excel(output_path + '1031_clinical_data.xlsx')\n",
    "# labels_nordic_all.to_excel(output_path + 'nordic_all_clinical_data.xlsx')\n",
    "# labels_mds_taml.to_excel(output_path + 'mds_taml_clinical_data.xlsx')\n",
    "# labels_all_graal.to_excel(output_path + 'all_graal_clinical_data.xlsx')\n",
    "# labels_target_all.to_excel(output_path + 'target_all_clinical_data.xlsx')\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Classification Strategy"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Later"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def process_df_labels(df):\n",
    "    \"\"\"\n",
    "    Function to process a pandas dataframe, performing age categorization \n",
    "    and main disease classification.\n",
    "\n",
    "    Args:\n",
    "        df (pandas.DataFrame): Input dataframe.\n",
    "\n",
    "    Returns:\n",
    "        pandas.DataFrame: Processed dataframe with age categorized and main disease classified.\n",
    "    \"\"\"\n",
    "    import numpy as np\n",
    "    import pandas as pd\n",
    "\n",
    "    def categorize_age(age):\n",
    "        \"\"\"\n",
    "        Function to categorize age into a specific range.\n",
    "\n",
    "        Args:\n",
    "            age (int or float): The age to be categorized.\n",
    "\n",
    "        Returns:\n",
    "            str: A string representation of the age category.\n",
    "        \"\"\"\n",
    "        if pd.isnull(age):\n",
    "            return np.nan\n",
    "        elif age < 5:\n",
    "            return '0-5'\n",
    "        elif age < 13:\n",
    "            return '5-13'\n",
    "        elif age < 39:\n",
    "            return '13-39'\n",
    "        elif age < 60:\n",
    "            return '39-60'\n",
    "        else:\n",
    "            return '60+'\n",
    "\n",
    "    def classify_main_disease(subtype):\n",
    "        \"\"\"\n",
    "        Function to classify the main disease based on a given subtype.\n",
    "\n",
    "        Args:\n",
    "            subtype (str): The subtype of the disease.\n",
    "\n",
    "        Returns:\n",
    "            str: A string representation of the main disease.\n",
    "        \"\"\"\n",
    "        mapping = {\n",
    "            'AML': 'Acute myeloid leukemia (AML)',\n",
    "            'ALL': 'Acute lymphoblastic leukemia (ALL)',\n",
    "            'MDS': 'Myelodysplastic syndrome (MDS or MDS-like)',\n",
    "            'Mixed phenotype acute leukemia': 'Mixed phenotype acute leukemia (MPAL)',\n",
    "            'APL': 'Acute promyelocytic leukemia (APL)',\n",
    "            'Otherwise-Normal Control': 'Otherwise-Normal (Control)'\n",
    "        }\n",
    "\n",
    "        for key, value in mapping.items():\n",
    "            if key in subtype:\n",
    "                return value\n",
    "\n",
    "    def main_disease_class(df):\n",
    "        \"\"\"\n",
    "        Function to classify the main disease and create a pathology class.\n",
    "\n",
    "        Args:\n",
    "            df (pandas.DataFrame): The dataframe to be processed.\n",
    "\n",
    "        Returns:\n",
    "            pandas.DataFrame: The processed dataframe with new columns for main disease and pathology class.\n",
    "        \"\"\"\n",
    "\n",
    "        df['WHO_ALL'] = df['WHO ALL 2022 Diagnosis'].astype(str).apply(classify_main_disease)\n",
    "        df['ELN_AML'] = df['ELN AML 2022 Diagnosis'].astype(str).apply(classify_main_disease)\n",
    "\n",
    "        df['Hematopoietic Group'] = df[['ELN_AML', 'WHO_ALL']] \\\n",
    "            .apply(lambda x: ','.join(filter(lambda i: i is not None and i == i, x)), axis=1) \\\n",
    "            .replace('', np.nan)\n",
    "\n",
    "        # Drop columns created except for `WHO Final Diagnosis` and `Combined Diagnosis` columns\n",
    "        df = df.drop(['ELN_AML', 'WHO_ALL'], axis=1)\n",
    "\n",
    "        return df\n",
    "\n",
    "    # Convert 'Age (years)' to numeric, errors='coerce' will turn non-numeric data to NaN\n",
    "    df['Age (years)'] = pd.to_numeric(df['Age (years)'], errors='coerce')\n",
    "\n",
    "    # Then apply your function\n",
    "    df['Age (group years)'] = df['Age (years)'].apply(categorize_age)\n",
    "    \n",
    "    # Process labels\n",
    "    df = main_disease_class(df)\n",
    "    \n",
    "    # Create `WHO 2022 Diagnosis` column\n",
    "    df['WHO 2022 Diagnosis'] = df[['WHO AML 2022 Diagnosis', 'WHO ALL 2022 Diagnosis']] \\\n",
    "            .apply(lambda x: ','.join(filter(lambda i: i is not None and i == i, x)), axis=1) \\\n",
    "            .replace('', np.nan)\n",
    "\n",
    "    return df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### WHO AML 2022 Diagnosis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "WHO AML 2022 Diagnosis\n",
       "AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement                           313\n",
       "MDS-related or secondary myeloid neoplasms                                230\n",
       "AML with mutated NPM1                                                     179\n",
       "AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11             178\n",
       "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1                                169\n",
       "Otherwise-Normal Control                                                  162\n",
       "AML with NUP98-fusion                                                      97\n",
       "AML with bZIP mutated CEBPA                                                69\n",
       "APL with t(15;17)(q24.1;q21.2)/PML::RARA                                   31\n",
       "AML with CBFA2T3::GLIS2 (inv(16)(p13q24))                                  30\n",
       "AML with t(6;9)(p23;q34.1)/DEK::NUP214                                     28\n",
       "AML with ETV6 fusion                                                       16\n",
       "AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement     10\n",
       "AML with t(1;22)(p13.3;q13.1); RBM15::MKL1                                  9\n",
       "AML with t(8;16)(p11.2;p13.3); KAT6A::CREBBP                                7\n",
       "AML with t(16;21)(p11;q22); FUS::ERG                                        4\n",
       "Myeloid leukemia associated with Down syndrome                              1\n",
       "Mixed phenotype acute leukemia T/myeloid                                    1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_labels['WHO AML 2022 Diagnosis'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### ELN AML 2022 Diagnosis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ELN AML 2022 Diagnosis\n",
       "AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement                           313\n",
       "MDS-related or secondary myeloid neoplasms                                228\n",
       "AML with other rare recurring translocations                              185\n",
       "AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11             178\n",
       "AML with mutated NPM1                                                     172\n",
       "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1                                169\n",
       "Otherwise-Normal Control                                                  162\n",
       "AML with in-frame bZIP mutated CEBPA                                       69\n",
       "APL with t(15;17)(q24.1;q21.2)/PML::RARA                                   31\n",
       "AML with t(6;9)(p23;q34.1)/DEK::NUP214                                     28\n",
       "AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement     10\n",
       "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1                                     3\n",
       "Myeloid leukaemia associated with Down syndrome                             1\n",
       "Mixed phenotype acute leukemia T/myeloid                                    1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_labels['ELN AML 2022 Diagnosis'].value_counts()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Evaluate final sample size by batch"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Batch\n",
       "GSE49031          933\n",
       "GSE190931         581\n",
       "GSE124413         495\n",
       "GSE159907         316\n",
       "GDC_TARGET-AML    287\n",
       "GDC_TCGA-AML      194\n",
       "GSE152710         166\n",
       "GSE147667         153\n",
       "GDC_TARGET-ALL    141\n",
       "GSE133986          64\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Batch'].value_counts(dropna=False)"
   ]
  }
 ],
 "metadata": {
  "celltoolbar": "Tags",
  "kernelspec": {
   "display_name": ".venv_sklearn",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.16"
  },
  "vscode": {
   "interpreter": {
    "hash": "bea0b97f2aeab51a41f683aa60895cc0e821b0a2b6d8fed7be73bd28506d07e0"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}